Baptist Health, Stage I Diagnostics Partner to Offer New Cancer Tests

by Arkansas Business Staff  on Wednesday, Oct. 11, 2017 4:47 pm   1 min read

Baptist Health of Little Rock has officially entered into an agreement with Stage I Diagnostics Inc. of Little Rock to offer Arkansans a test with prognostic and diagnostic value in the earliest stages of cancer.

The tests quantitatively measure the levels/expression of certain aggressive cancer causing proteins in the blood with a simple blood test.

Stage I was founded by Dr. Timothy O’Brien in 2005 at the University of Arkansas for Medical Sciences’ BioVentures.

Greg Stubblefield, vice president of clinical services at Baptist, said in a news release, “We are excited to work with Stage I in ensuring that Arkansans have access to the newest technology in the state, consistent with Baptist Health’s mission to respond to the changing health needs of the citizens of Arkansas.”

"Stage I is an Arkansas-based company. It is only fitting that we partner with a well respected, community focused organization like Baptist Health in achieving our goal of early diagnosis and prognosis in a variety of cancers. Our assays will be informative for physicians and affordable for all Arkansans” said Stage I CEO Don E. Fowler.

 

 

Please read our comments policy before commenting.
Search